Phytotherapy in neurology: the dual face of natural medicines – a review of the therapeutic potential and toxicological risks

Phytotherapy in neurology: the dual face of natural medicines – a review of the therapeutic potential and toxicological risks

Authors

  • Elisângela Aparecida Comparsi  Author
  • Milena Ribeiro Borges Author

DOI:

https://doi.org/10.51473/rcmos.v1i2.2025.1584

Keywords:

Toxicity. Biological Products. Phytotherapy. Nervous System. Adverse Drug Events

Abstract

The use of phytotherapics and medicinal plants has become increasingly popular due to the perception that they offer safer and more affordable alternatives to conventional drugs. However, despite their benefits, the toxicity of these treatments, often underestimated, can pose significant health risks. This study aimed to investigate the therapeutic potential and toxicological risks of phytotherapics and medicinal plants used in the treatment of neurological disorders such as epilepsy, Alzheimer’s disease, Parkinson’s disease, and others. The research was conducted through an integrative literature review, selecting recent scientific studies that evaluate the benefits and adverse effects of these compounds. The main factors contributing to toxicity were analyzed, including inappropriate dosages, drug interactions, and the lack of professional guidance. Data were collected from reliable sources such as PubMed, Scopus, and Google Scholar, using the descriptors: toxicity, natural product, phytotherapy, nervous system, and adverse effects.  The results highlight the need for a broader understanding of the risks associated with the indiscriminate use of phytotherapics and medicinal plants, emphasizing the importance of a cautious, evidence-based approach supervised by healthcare professionals. Furthermore, the findings contribute to the development of more rigorous guidelines for the use of these natural compounds, promoting greater safety and efficacy in the treatment of nervous system disorders. The study also reinforces the importance of patient education and the establishment of practical guidelines for healthcare providers to ensure monitored use and appropriate intervention in cases of adverse reactions. 

Downloads

Download data is not yet available.

References

ALMEIDA, J. R.; SILVA, F. R.; PEREIRA, L. A. Melissa officinalis L.: pharmacological properties, therapeutic potential and safety. Journal of Ethnopharmacology, v. 299, p. 114–123, 2024.

BARBOSA, R. A.; PEREIRA, L. S. Uso de fitoterápicos no tratamento de doenças neurológicas: benefícios e riscos. Revista de Farmacologia e Terapêutica, v. 25, n. 4, p. 235-250, 2020.

BORGES, FLÁVIA GOMES et al. Promoção da fitoterapia no tratamento de transtornos neurológicos. Research, Society and Development, v. 11, n. 11, e22281111764, 2022.

BRASIL. Ministério da Saúde. Plantas medicinais e fitoterápicos. Brasília, DF: Ministério da Saúde, 2023. Disponível em: https://www.gov.br/saude/pt-br/composicao/sectics/plantas-medicinais-e-fitoterapicos

. Acesso em: 2 set. 2025.

CARVALHO, F. M.; FERREIRA, J. S.; PASSOS, L. A. O uso de fitoterápicos no tratamento da ansiedade: uma revisão de literatura. Research, Society and Development, v. 13, n. 6, e11813646095, 2025. DOI: https://doi.org/10.33448/rsd-v13i6.46095

CHANDRAN, R. Identifying Plant-Based Natural Medicine against Oxidative Stress in Neurodegenerative Diseases. 2020. Disponível em: https://pmc.ncbi.nlm.nih.gov/articles/PMC7519196/ DOI: https://doi.org/10.1155/2020/8648742

. Acesso em: 16 out. 2025.

COSTA, M. T.; ALMEIDA, F. C. Regulamentação e segurança no uso de fitoterápicos: desafios e avanços. Jornal de Ciências da Saúde, v. 15, n. 3, p. 178-193, 2022.

DESAI, V.; SHAIKHSURAB, M. Z.; VARGHESE, N.; ASHTEKAR, H. Assessing the anti-inflammatory effects of Bacopa-derived bioactive compounds using network pharmacology and in vitro studies. In Silico Pharmacology, v. 12, n. 2, p. 98, 2025.

GENCHI, G.; SANTORO, M.; PELLEGRINI, M.; et al. Neuroprotective Effects of Curcumin in Neurodegenerative Diseases. Foods, v. 13, n. 11, p. 1774, 2024. DOI: 10.3390/foods13111774. DOI: https://doi.org/10.3390/foods13111774

FATIMA, UROOJ et al. Pharmacological attributes of Bacopa monnieri extract: Current updates and clinical manifestation. Frontiers in Nutrition, v. 9, p. 972379, 2022. DOI: https://doi.org/10.3389/fnut.2022.972379

FREITAS, P. F.; SOUZA, D. S. A toxicidade de medicamentos naturais: implicações para a prática clínica em doenças neurológicas. Cadernos de Pesquisa Médica, v. 31, n. 1, p. 22-35, 2021.

LIMA, M. C. et al. Uso de plantas medicinais e fitoterápicos no Brasil: uma revisão integrativa. Revista Brasileira de Ciências da Saúde, v. 19, n. 1, p. 67-74, 2021.

LOPES, V. et al. Exploring pharmacological mechanisms of lavender (Lavandula angustifolia). Frontiers in Pharmacology, v. 8, p. 280, 2017. DOI: https://doi.org/10.3389/fphar.2017.00280

MENDONÇA NETO, I. J. de et al. Medicinal plants and herbal medications in the treatment of anxiety: a systematic review. Revista de Ciências Farmacêuticas Básica e Aplicada, v. 43, n. 3, p. 1-13, 2022.

MOREIRA, J. R.; GOMES, R. L. Efeitos adversos e interações medicamentosas de fitoterápicos: uma revisão sobre a toxicidade em tratamentos neurológicos. Revista de Toxicologia e Medicamentos Naturais, v. 12, n. 2, p. 142-157, 2023.

ORGANIZAÇÃO MUNDIAL DA SAÚDE (OMS). Neurological disorders: public health challenges. Geneva: WHO, 2023.

ROCHA, L. P. B. da. Uso de plantas medicinais: histórico e relevância. 2021. Disponível em: https://rsdjournal.org/rsd/article/download/18282/16571/230446

. Acesso em: 16 out. 2025.

SILVA, A. P.; CASTRO, R. M. Fitoterápicos e seus riscos: revisão sobre a toxicidade e os efeitos adversos no tratamento de doenças neurológicas. Jornal Brasileiro de Toxicologia e Farmacologia, v. 28, n. 5, p. 1015-1027, 2019.

SOUSA, FRANCISCA C. F. et al. Plantas medicinais e seus constituintes bioativos: uma revisão da bioatividade e potenciais benefícios nos distúrbios da ansiedade em modelos animais. Revista Brasileira de Farmacognosia, v. 32, p. 205–220, 2022.

SOUZA, A. M. et al. Kava-kava: toxicidade e interações medicamentosas. Revista de Toxicologia e Farmacologia, v. 10, n. 3, p. 54-63, 2019.

VELASQUEZ, A. C. A. et al. Effects of Passiflora incarnata and Valeriana officinalis in the control of anxiety due to tooth extraction: a randomized controlled clinical trial. Journal of Clinical Medicine, v. 13, n. 1, p. 1-10, 2024.

TAN, M. S.; YANG, Y.; ZHANG, L.; WANG, H. F.; LIU, Y.; JIANG, T. Ginkgo biloba extract in the treatment of cognitive impairment and dementia: A systematic review of randomized clinical trials. Journal of Ethnopharmacology, v. 175, p. 1-15, 2015.

ZENI, FRANCIELLE et al. Plantas medicinais e fitoterápicos na promoção à saúde no transtorno de ansiedade: uma revisão da literatura de apoio aos profissionais. Revista Infarma – Ciências Farmacêuticas, v. 35, n. 1, p. 126–138, 2023.

Published

2025-10-24

How to Cite

COMPARSI , Elisângela Aparecida; BORGES , Milena Ribeiro. Phytotherapy in neurology: the dual face of natural medicines – a review of the therapeutic potential and toxicological risks: Phytotherapy in neurology: the dual face of natural medicines – a review of the therapeutic potential and toxicological risks. Multidisciplinary Scientific Journal The Knowledge, Brasil, v. 1, n. 2, 2025. DOI: 10.51473/rcmos.v1i2.2025.1584. Disponível em: https://submissoesrevistarcmos.com.br/rcmos/article/view/1584. Acesso em: 18 nov. 2025.